Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer. [PDF]
Katims AB +24 more
europepmc +1 more source
Low-Cost Pathology Signals for Risk Stratification in High-Risk Non-Muscle-Invasive Bladder Cancer: A Narrative Review. [PDF]
Sala-González N +7 more
europepmc +1 more source
Complete Response to Intravesical BCG for High-Risk pT1 Bladder Cancer With Lymphovascular Invasion: A Case Report. [PDF]
Saad A +3 more
europepmc +1 more source
Blood Pressure Changes After Oral 5-Aminolevulinic Acid Hydrochloride Administered 4-8 h Before TURBT: An Additional Analysis of a Phase III Study (SPP2C102). [PDF]
Fukuhara H +11 more
europepmc +1 more source
When a ‘routine’ TURBT is not routine: Lessons from SEER-medicare
Malshy, Kamil, Messing, Edward M.
openaire +3 more sources
Submucosal urothelial cancer of bladder: A case report. [PDF]
Sappayasarn S +5 more
europepmc +1 more source
Early Classification of Bladder Cancer Using Spectrum-Aided Visual Enhancer (SAVE) and Deep Learning Models: A Non-Invasive Technology for Faster Detection. [PDF]
Yang MH +7 more
europepmc +1 more source
Trans-renal ureteral occlusion for the management of persistent intraperitoneal bladder leak. [PDF]
Bolton J +4 more
europepmc +1 more source
Neoadjuvant Intravesical Mitomycin C for NMIBC: A Phase III Single-Center, Open-Label Randomized Clinical Trial. [PDF]
Contieri R +21 more
europepmc +1 more source

